tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
RGNX is currently covered by 9 analysts with an average price target of $23.82. This is a potential upside of $19.13 (115.37%) from yesterday's end of day stock price of $11.06.
Regenxbio's activity chart (see below) currently has 120 price targets and 123 ratings on display. The stock rating distribution of RGNX is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 21.44% with an average time for these price targets to be met of 63.52 days.
Highest price target for RGNX is $45, Lowest price target is $12, average price target is $23.82.
Most recent stock forecast was given by YI CHEN from HC WAINWRIGHT on 10-Aug-2026. First documented stock forecast 12-Oct-2015.
Currently out of the existing stock ratings of RGNX, 23 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 11-Mar-2024
$23
$12.23 (113.56%)
$26
Buy Since 22-Nov-2017
$12
$1.23 (11.42%)
$12
Buy Since 02-Jun-2023
$32
$21.52 (205.34%)
$39
Buy Since 15-Dec-2025
$18
$7.52 (71.76%)
$20
Buy Since 15-Nov-2024
$17
$6.52 (62.21%)
$18
What is RGNX (Regenxbio) average time for price targets to be met?
Which analyst has the current highest performing score on RGNX (Regenxbio) with a proven track record?
Which analyst has the most public recommendations on RGNX (Regenxbio)?
Which analyst is the currently most bullish on RGNX (Regenxbio)?
Which analyst is the currently most reserved on RGNX (Regenxbio)?
